Clinical Study
Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease
Table 1
Demographic and baseline serum biochemistries of patients in the study and control groups.
| | Variable | Study group
() | Control group
() | P value |
| | Age (years) | | | NS | | Diabetes | 3 (37.5%) | 3 (33.3%) | NS | | Phosphate (mg/dL) | 4.2 (3.7–4.5) | 4.4 (3.8–4.8) | NS | | Calcium (mg/dL) | 8.9 (8.3–9.7) | 9.0 (8.5–9.9) | NS | | Ca × P (mg2/dL2) | 37 (35–42) | 39 (34–43) | NS | | Intact PTH (pg/mL) | 201 (166–228) | 136 (127–148) | <0.01 | | hs-CRP (mg/L) | 4.9 (3.3–7.7) | 4.9 (3.9–8.0) | NS | | TNF- (pg/mL) | 7.8 (5.1–9.0) | 7.6 (5.5–9.2) | NS | | Interleukin-6 (pg/mL) | 6.5 (2–12) | 6.8 (2.8–11.2) | NS | | Interleukin-10 (pg/mL) | 67 (41–125) | 72 (32–101) | NS |
|
|
Ca × P: calcium-phosphate product; PTH: parathyroid hormone; hs-CRP: high-sensitive C-reactive protein; TNF-: tumor necrosis factor-; NS: not significant.
|
